Skip to main content
Difficult-to-treat chronic migraine: OnabotulinumtoxinA to anti-CGRP mAbs switch shows benefit
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Difficult-to-treat chronic migraine: OnabotulinumtoxinA to anti-CGRP mAbs switch shows benefit
User login
Username
Password
Reset your password
Concept
Lead
score
Migraine
1
1
Botulinum Toxin in Pain Management
0
0.85
Monoclonal Antibody
0
0.58
Biologic Therapy
0
0.85
Headache
0
0.12
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Family Medicine/Primary Care
0
1
Pharmacist
0
0.21
Edit Tags